Newsroom
May 1, 2018
CHO CD02, CHO CD04, and CHO Feed02 were launched
QuaCell was awarded the Specialized and Sophisticated Enterprises for 2022 in Guangdong Province
April 23, 2023
QuaCell Was Named to Top 100 Life Sciences Services Corporate Brands
December 10, 2022
QuaCell Delivered Sample Production of Agonistic Antibody Program Clinical Phase I and Signed Agreement on Strategic Cooperation with Constimulus
QuaCell's Initiation of Suzhou Manufacturing Site
QuaCell has been Named to Biotechnology Innovation 50 List
November 1, 2022
Drug Master Files (DMF) are available for the QuaCell® CHO cell culture medium series, facilitating antibody drug projects filing
October 27, 2022
